These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 18082375)

  • 1. In vitro synergism between rokitamycin and co-trimoxazole against Streptococcus pyogenes, Streptococcus pneumoniae and staphylococci.
    Roveta S; Marchese A; Debbia EA; Bandettini R
    Int J Antimicrob Agents; 2008 Feb; 31(2):185-7. PubMed ID: 18082375
    [No Abstract]   [Full Text] [Related]  

  • 2. The post-antibiotic effects of rokitamycin (a 16-membered ring macrolide) on susceptible and erythromycin-resistant strains of Streptococcus pyogenes.
    Braga PC; Culici M; Dal Sasso M
    Int J Antimicrob Agents; 2004 Sep; 24(3):254-60. PubMed ID: 15325429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the degree of susceptibility of Streptococcus pyogenes erythromycin-resistant strains to rokitamycin (a 16-membered macrolide) using the Epsilometer test.
    Crotti D; Rossetti R; Braga PC
    Drugs Exp Clin Res; 2004; 30(1):17-26. PubMed ID: 15134387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial activity of the new macrolide flurithromycin against Haemophilus influenzae, Streptococcus pneumoniae, Streptococcus pyogenes, Branhamella catarrhalis and Staphylococcus aureus.
    Nord CE; Lindmark A; Persson I
    J Chemother; 1989 Jul; 1(4 Suppl):203-4. PubMed ID: 16312369
    [No Abstract]   [Full Text] [Related]  

  • 5. [Streptococcus pyogenes and resistance to macrolides: experience at Monza].
    Minerva Pediatr; 1998; 50(1-2):XII-XIII. PubMed ID: 9658791
    [No Abstract]   [Full Text] [Related]  

  • 6. Susceptibility of Staphylococcus aureus, Streptococcus pyogenes and Diplococcus pneumoniae to antibiotics. Comparison of patterns in Poland and Federal Republic of Germany.
    Jeljaszewicz J; Stochmal I; Dajek Z; Pulverer G; Hryniewicz W; Cybulska J; Switalski LM; Dziarski R
    Zentralbl Bakteriol Orig A; 1976 Aug; 235(4):376-85. PubMed ID: 10702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of novel lincomycin derivatives and their in vitro antibacterial activities.
    Umemura E; Wakiyama Y; Kumura K; Ueda K; Masaki S; Watanabe T; Yamamoto M; Hirai Y; Fushimi H; Yoshida T; Ajito K
    J Antibiot (Tokyo); 2013 Mar; 66(3):195-8. PubMed ID: 23232934
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro activity of novel rifamycins against gram-positive clinical isolates.
    Murphy CK; Karginova E; Sahm D; Rothstein DM
    J Antibiot (Tokyo); 2007 Sep; 60(9):572-6. PubMed ID: 17917240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro sensitivity of hemophilus influenzae and streptococcus pyogenes to co-trimoxazole.
    Leers WD
    Can Med Assoc J; 1975 Jun; 112(13 Spec No):59-63. PubMed ID: 1093653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and microbiological evaluation of miocamycin activity against group A beta-haemolytic streptococci in pediatric patients. Three years' incidence of erythromycin-resistant group A streptococci.
    Borzani M; Varotto F; Garlaschi L; Conio F; Dell'Olio M; Careddu P
    J Chemother; 1989 Jul; 1(4 Suppl):392-4. PubMed ID: 16312455
    [No Abstract]   [Full Text] [Related]  

  • 11. Differences in the susceptibility of Streptococcus pyogenes to rokitamycin and erythromycin A revealed by morphostructural atomic force microscopy.
    Braga PC; Ricci D
    J Antimicrob Chemother; 2002 Oct; 50(4):457-60. PubMed ID: 12356788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antibacterial activity of co-trimoxazole and tetroxoprim/sulfadiazine in vitro (author's transl)].
    Hahn H; Kirov A
    Arzneimittelforschung; 1980; 30(7):1047-8. PubMed ID: 7191284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bacteriostatic and bactericidal effect of 7-chloro-7-desoxylincomycin on staphylococci, streptococci and pneumococci].
    Modde H
    Schweiz Med Wochenschr; 1971 Nov; 101(45):1629-31. PubMed ID: 4401247
    [No Abstract]   [Full Text] [Related]  

  • 14. Design, synthesis, and antibacterial activities of novel 3,6-bicyclolide oximes: length optimization and zero carbon linker oximes.
    Tang D; Gai Y; Polemeropoulos A; Chen Z; Wang Z; Or YS
    Bioorg Med Chem Lett; 2008 Sep; 18(18):5078-82. PubMed ID: 18762418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antistreptococcal activity of AR-709 compared to that of other agents.
    Smith K; Ednie LM; Appelbaum PC; Hawser S; Lociuro S
    Antimicrob Agents Chemother; 2008 Jun; 52(6):2279-82. PubMed ID: 18362189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergy between gemifloxacin and trimethoprim/sulfamethoxazole against community-associated methicillin-resistant Staphylococcus aureus.
    Leonard SN; Kaatz GW; Rucker LR; Rybak MJ
    J Antimicrob Chemother; 2008 Dec; 62(6):1305-10. PubMed ID: 18801920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of antibacterial activities of Albizia gummifera and Ferula communis on Streptococcus pneumoniae and Streptoccus pyogenes.
    Unasho A; Geyid A; Melaku A; Debela A; Mekasha A; Girma S; Kebede T; Fantaw S; Asaminew N; Mamo K
    Ethiop Med J; 2009 Jan; 47(1):25-32. PubMed ID: 19743777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antibacterial activity of rokitamycin against fresh clinical isolates].
    Deguchi K; Yokota N; Koguchi M; Suzuki Y; Suzuki K; Fukayama S; Ishihara R; Oda S
    Jpn J Antibiot; 1992 Dec; 45(12):1609-21. PubMed ID: 1289579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of the investigational ketolide cethromycin against macrolide- and penicillin-resistant Streptococcus pneumoniae: review of the 1998 to 2006 Canadian Respiratory Organism Susceptibility Study (CROSS).
    Wierzbowski AK; Karlowsky JA; Hoban DJ; Zhanel GG
    J Antimicrob Chemother; 2009 Mar; 63(3):620-2. PubMed ID: 19151038
    [No Abstract]   [Full Text] [Related]  

  • 20. In vitro activity of AR-709 against Streptococcus pneumoniae.
    Jansen WT; Verel A; Verhoef J; Milatovic D
    Antimicrob Agents Chemother; 2008 Mar; 52(3):1182-3. PubMed ID: 18180358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.